195 related articles for article (PubMed ID: 26610650)
21. A Clinical Approach to Chronic Diarrhea.
Dutra B; Siddiqui S; Everett J
Gastroenterology; 2022 Mar; 162(3):707-709. PubMed ID: 34331913
[No Abstract] [Full Text] [Related]
22. Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.
Mandavdhare HS; Sharma V; Prasad KK; Kumar A; Rathi M; Rana SS
Intest Res; 2017 Jul; 15(3):419-421. PubMed ID: 28670240
[TBL] [Abstract][Full Text] [Related]
23. Five cases of sprue-like enteropathy in patients treated by olmesartan.
Théophile H; David XR; Miremont-Salamé G; Haramburu F
Dig Liver Dis; 2014 May; 46(5):465-9. PubMed ID: 24472297
[TBL] [Abstract][Full Text] [Related]
24. An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy.
Mauloni PA; Capuani F; Paone C; Marasco G; Bellacosa L; Cogliandro RF; Cremon C; Barbara G; Vasuri F; Stanghellini V
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1060-e1066. PubMed ID: 34334714
[TBL] [Abstract][Full Text] [Related]
25. Clinical-Pathological Conference Series from the Medical University of Graz : Case No 166: An 82-year-old woman with voluminous diarrhea and weight loss.
Fabian E; Roskaric T; Pfeifer J; Wenzl H; Hammer HF; Lackner C; Rosanelli G; Krejs GJ
Wien Klin Wochenschr; 2023 Aug; 135(15-16):429-435. PubMed ID: 36534207
[No Abstract] [Full Text] [Related]
26. Two coincident cases of easily curable 'refractory sprue'.
Schiller D; Ziachehabi A; Silye R; Schöfl R
Gut; 2015 Nov; 64(11):1714, 1773. PubMed ID: 25717152
[No Abstract] [Full Text] [Related]
27. In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.
de Araújo AA; Borba PB; de Souza FH; Nogueira AC; Saldanha TS; Araújo TE; da Silva AI; de Araújo Júnior RF
Biol Pharm Bull; 2015; 38(5):746-52. PubMed ID: 25947920
[TBL] [Abstract][Full Text] [Related]
28. [A new spruelike disease as a cause of severe diarrhea].
Halevy D; Teeuwen U; Kohlhof P
Dtsch Med Wochenschr; 2014 Nov; 139(45):2290-3. PubMed ID: 25350242
[TBL] [Abstract][Full Text] [Related]
29. Case of photosensitivity after the administration of olmesartan medoxomil.
Ozaki C; Ohnishi S; Yu A; Moriwaki S
J Dermatol; 2018 Oct; 45(10):e277-e278. PubMed ID: 29603756
[No Abstract] [Full Text] [Related]
30. A case report of olmesartan-associated sprue-like enteropathy: Diagnosis and healing confirmed by capsule endoscopy.
Yamaguchi Y; Miwa T; Murakami R; Sugimura A; Yamamoto K; Sugiyama T; Tamura Y; Izawa S; Ebi M; Funaki Y; Ogasawara N; Sasaki M; Kasugai K
DEN Open; 2023 Apr; 3(1):e142. PubMed ID: 35898826
[TBL] [Abstract][Full Text] [Related]
31. In brief: Olmesartan and sprue-like enteropathy.
Med Lett Drugs Ther; 2018 Jan; 60(1539):24. PubMed ID: 29364200
[No Abstract] [Full Text] [Related]
32. [Enteropathy by olmesartan].
Téllez Villajos L; Crespo Pérez L; Cano Ruiz A; Moreira Vicente V
Med Clin (Barc); 2015 Feb; 144(3):140-1. PubMed ID: 25194976
[No Abstract] [Full Text] [Related]
33. [Enteropathy associated with chronic use of olmesartan].
Téllez A; Pellicé M; Llobell A; Milisenda JC
Med Clin (Barc); 2015 Feb; 144(3):139-40. PubMed ID: 24930862
[No Abstract] [Full Text] [Related]
34. An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
Imperatore N; Tortora R; Capone P; Caporaso N; Rispo A
Scand J Gastroenterol; 2016 Mar; 51(3):378-80. PubMed ID: 26554620
[No Abstract] [Full Text] [Related]
35. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan.
Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J
Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786
[No Abstract] [Full Text] [Related]
36. Small bowel enteropathy associated with olmesartan medoxomil treatment.
Galanopoulos M; Varytimiadis L; Tsigaridas A; Karatzas PS; Archavlis E; Viazis N; Vourlakou C; Mantzaris GJ
Ann Gastroenterol; 2017; 30(1):131-133. PubMed ID: 28042253
[TBL] [Abstract][Full Text] [Related]
37. Collagenous Sprue and Olmesartan: another pathological condition related to this drug.
Del Sordo R; Villanacci V; Oberti A; Moneghini D; Mocci G
Dig Liver Dis; 2021 Nov; 53(11):1524-1526. PubMed ID: 34219045
[No Abstract] [Full Text] [Related]
38. A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper.
Xue A; Fowler MR; Silverman J; Sturkie E; Raff E
Cureus; 2023 Jul; 15(7):e41604. PubMed ID: 37559845
[TBL] [Abstract][Full Text] [Related]
39. Severe Sprue-Like Enteropathy and Colitis due to Olmesartan: Lessons Learned From a Rare Entity.
Bashari DR
Gastroenterology Res; 2020 Aug; 13(4):150-154. PubMed ID: 32864026
[TBL] [Abstract][Full Text] [Related]
40. Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea.
Sotiropoulos C; Sakka E; Diamantopoulou G; Theocharis GJ; Thomopoulos KC
Cureus; 2021 Aug; 13(8):e17004. PubMed ID: 34540405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
